(Q37593392)

21 August 2017

The impact of genetic variants in inflammatory-related genes on prostate cancer risk among men of African Descent: a case control study (English)

1 reference

21 August 2017

1 reference

Dominique Z Jones

1

1 reference

21 August 2017

Camille Ragin

2

1 reference

21 August 2017

Nayla C Kidd

3

1 reference

21 August 2017

Rafael E Flores-Obando

4

1 reference

21 August 2017

Maria Jackson

5

1 reference

21 August 2017

Norma McFarlane-Anderson

6

1 reference

21 August 2017

Marshall Tulloch-Reid

7

1 reference

21 August 2017

Kevin S Kimbro

8

1 reference

21 August 2017

Lacreis R Kidd

9

1 reference

21 August 2017

23 December 2013

1 reference

Hereditary Cancer in Clinical Practice

21 August 2017

1 reference

21 August 2017

11

1 reference

21 August 2017

1

1 reference

21 August 2017

19

1 reference

https://scigraph.springernature.com/pub.10.1186/1897-4287-11-19

21 August 2017

0 references

cites work

Chemokine Ligand 5 (CCL5) and chemokine receptor (CCR5) genetic variants and prostate cancer risk among men of African Descent: a case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929257

Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrence

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929257

Prostate cancer and inflammation: the evidence

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929257

Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929257

TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929257

Finding the missing heritability of complex diseases

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929257

Cytokine genetic polymorphisms and prostate cancer aggressiveness

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929257

Inflammation and prostate cancer.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929257

PGA: power calculator for case-control genetic association analyses.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929257

Genome-wide association studies for complex traits: consensus, uncertainty and challenges

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929257

Whole genome genotyping technologies on the BeadArray platform

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929257

23 August 2017

Inflammation and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929257

Genetic susceptibility and gastric cancer risk.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929257

Cytokines in acute and chronic inflammation

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929257

Interactions of cytokine gene polymorphisms in prostate cancer risk.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929257

IL-10 -1082 G>A: a risk for prostate cancer but may be protective against progression of prostate cancer in North Indian cohort

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929257

Ectopic expression of interleukin-1 receptor type II enhances cell migration through activation of the pre-interleukin 1alpha pathway.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929257

Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929257

Significance of Tumor necrosis factor α-308 (G/A) gene polymorphism in the development of prostate cancer.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929257

Genetic variants in interleukin-2 and risk of lymphoma among children in Korea.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929257

Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929257

RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929257

Interleukin-6 promoter variants, prostate cancer risk, and survival

1 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1897-4287-11-19

Comprehensive analysis of the cytokine-rich chromosome 5q31.1 region suggests a role for IL-4 gene variants in prostate cancer risk

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1897-4287-11-19

Estudio genético de RNASEL en cáncer de próstata y su relación con la estadificación clínica

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1897-4287-11-19

Associations of whole-blood fatty acids and dietary intakes with prostate cancer in Jamaica

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24359571

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Influence of cytokine gene polymorphisms on prostate-specific antigen recurrence in prostate cancer after radical prostatectomy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24359571

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24359571

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1897-4287-11-19

1 reference

Dimensions Publication ID

21 August 2017

0 references

1 reference

21 August 2017

PubMed publication ID

24359571

1 reference